Author

Bleiker Tanja

University Children's Hospital Zurich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

Amin AllalouiD· 1 shared Bernard CirauloiD· 1 shared Dejana Versamento· 1 shared Dina Hochuli· 1 shared Levi Luca KoppiD· 1 shared Marc Thomas Schönholzer· 1 shared Martin BaumgartneriD· 1 shared Meng-Syuan LiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amin AllalouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MAP4K inhibition by the CNS penetrant inhibitor famlasertib restrains medulloblastoma dissemination without developmental toxicity

Marc Thomas Schönholzer, Meng-Syuan Lin, Shen Yan, Veronica Akle Alvarez, Amin Allalou, Bernard Ciraulo, Dejana Versamento, Levi Luca Kopp, Dina Hochuli, Bleiker Tanja, Welti Annik, Stephan C. F. Neuhauss, Martin Baumgartner

This study shows that famlasertib, a MAP4K inhibitor, reduces medulloblastoma cell invasion in vitro and in zebrafish models without causing developmental toxicity.

bioRxiv · Jul 23, 2026 · PreprintCancer Biology